| __timestamp | Amphastar Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 13608000 |
| Thursday, January 1, 2015 | 251519000 | 48257000 |
| Friday, January 1, 2016 | 255165000 | 26353000 |
| Sunday, January 1, 2017 | 240175000 | 25186000 |
| Monday, January 1, 2018 | 294666000 | 20653000 |
| Tuesday, January 1, 2019 | 322357000 | 48835000 |
| Wednesday, January 1, 2020 | 349846000 | 17812000 |
| Friday, January 1, 2021 | 437768000 | 157170000 |
| Saturday, January 1, 2022 | 498987000 | 270827000 |
| Sunday, January 1, 2023 | 644395000 | 331412000 |
Data in motion
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have shown distinct revenue trajectories from 2014 to 2023. Amphastar's revenue has surged by over 200%, from approximately $210 million in 2014 to $644 million in 2023. This consistent growth highlights their strategic market positioning and product innovation. In contrast, BioCryst's revenue, while starting at a modest $13.6 million in 2014, has experienced a remarkable increase, reaching $331 million in 2023, marking a growth of over 2300%. This dramatic rise underscores BioCryst's successful product launches and market expansion. The data reveals a compelling narrative of two companies navigating the pharmaceutical industry's challenges and opportunities, each carving out a unique path to financial success.
Revenue Insights: Pfizer Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Revenue Insights: Pfizer Inc. and BioCryst Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Revenue Showdown: BeiGene, Ltd. vs BioCryst Pharmaceuticals, Inc.
United Therapeutics Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Genmab A/S and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Dr. Reddy's Laboratories Limited and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
ACADIA Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Amphastar Pharmaceuticals, Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Taro Pharmaceutical Industries Ltd. vs BioCryst Pharmaceuticals, Inc.
Breaking Down Revenue Trends: BioCryst Pharmaceuticals, Inc. vs Evotec SE